Navigation Links
New TB vaccine approach shows promise in mice
Date:9/6/2011

An experimental vaccine composed of a genetically modified bacterium closely related to the bacterium that causes tuberculosis (TB) has been found to protect mice against TB infection, according to a study appearing online September 4 in the journal Nature Medicine. The research was funded in part by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health.

TB, a respiratory disease that according to World Health Organization estimates killed 1.7 million people worldwide in 2009, is caused by the bacterium Mycobacterium tuberculosis (Mtb). A vaccine to prevent TB infection, called bacille Calmette-Gurin (BCG), is widely available, but it confers limited protection and can cause severe TB infection in infants infected with HIV, restricting its use in certain countries.

In the new study, led by William R. Jacobs, Jr., Ph.D., of the Albert Einstein College of Medicine in New York, researchers genetically modified M. smegmatis, a relative of Mtb that is generally harmless to humans. Specifically, the scientists replaced a set of M. smegmatis genes called esx-3, believed to be important because its DNA sequence is unusually consistent across species, with the corresponding but not identical set of genes from Mtb. They vaccinated mice with this modified form of M. smegmatis, essentially delivering the Mtb version of esx-3 without the bacterial components that would cause infection, and then challenged the mice with Mtb. In mice that received the experimental vaccine, levels of TB bacteria were 1,000 times lower than in those that received BCG. This suggests that modified M. smegmatis induces a strong immune response in mice that can protect them from TB.

The study authors are encouraged by their study results, but they caution that further testing of the modified M. smegmatis TB vaccine is needed before it might be evaluated in human clinical trials.


'/>"/>

Contact: Nalini Padmanabhan
padmanabhannm@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. More U.S. Tweens Getting Recommended Vaccines
2. GEN reports on advances in DNA vaccine delivery and production
3. Single vaccines to protect against both rabies and Ebola
4. U.S.-Mandated Report Finds Vaccines Safe for Kids
5. Few health problems are caused by vaccines, IOM report finds
6. Kids Benefit From Flu Vaccine via Shot or Spray, Study Finds
7. Mayo Clinic receives FDA approval for ovarian and breast cancer vaccines
8. Researchers create new experimental vaccine against chikungunya virus
9. New TB vaccine enters proof-of-concept trial in people living with HIV
10. Fine-tuning the flu vaccine for broader protection
11. Vaccine to Prevent Heroin High Works in Animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... LEXINGTON, Ky. (PRWEB) , ... October 13, 2017 , ... ... MD, MPH to become its next President and Chief Executive Officer, succeeding Dr. James ... and CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
Breaking Medicine Technology: